Researchers & Healthcare Professionals

CML - Diagnosis and Treatment Update

Note: The free Adobe Acrobat Reader® is required to view and print Adobe PDF files, and the free Windows Media Player or RealPlayer is required to listen to the MP3 audio files.

Date: November 08, 2012
CE Credit Available Until: June 20, 2014
Location: Virtual Lecture
Target Audience: Oncology nurses and social workers involved in the treatment of CML
Read: CML News Links | Program Slides | Transcript
Listen: Presentation  | Q&A Session
Access: Virtual Lecture 

Activity Purpose

To educate oncology nurses and social workers about chronic myeloid leukemia (CML) diagnosis and treatment

Educational Objectives

At the conclusion of this program, participants should be able to:

  • Identify CML treatment options in an era of multiple approved oral therapy drugs
  • Outline discussion points between patients and their healthcare teams to help with treatment decisions
  • Explain the importance of monitoring treatment response and follow-up screenings
  • Describe psychosocial aspects of living with a chronic cancer
  • List resources to help patients manage the impact of costs associated with CML treatment


Neil P. Shah, MD, PhD
Associate Professor in Residence
Edward S. Ageno Distinguished Professor of Hematology/Oncology
, Hematopoietic Malignancies Program,
Helen Diller Family Comprehensive Cancer Center at University of California at San Francisco
San Francisco, CA

Sponsors and Supporters

This program is sponsored by The Leukemia & Lymphoma Society and supported by a grant from Novartis Oncology.

last updated on Thursday, December 20, 2012